
09/11/2025
We’re excited to partner with the Patterson Institute for Integrative Cancer Research on a new clinical study investigating how Maitake mushrooms might support treatment.
If you’re 18+ and currently receiving or taking CDK4/6 inhibitors (like Ibrance, Kisqali, or Verzenio), and can travel to or , you may be eligible to participate.
The 12-week study includes four in-person visits, and participants will receive VISA gift cards as a thank-you.
Learn more and see if you qualify: thechi.ca/research-study